Osteoporosis International

, Volume 21, Issue 2, pp 275–285 | Cite as

Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women

Original Article

Abstract

Summary

The relationship between the levels of gonadotropic hormones and bone metabolism in Chinese adult women is unclear. Our research shows that a significant positive correlation exists between the levels of gonadotropic hormones and various bone turnover indicators. Follicle-stimulating hormone (FSH) has been found to have a greater influence on all types of bone turnover indicator than luteinizing hormone (LH). Further, FSH has a greater influence on bone formation indicators than on bone resorption indicators.

Introduction

The aim of this study was to investigate the relationship between serum FSH and LH and biochemical markers of bone turnover in native Chinese adult women.

Methods

We conducted a cross-sectional study of 694 healthy Chinese women aged between 20 and 82 years. Serum FSH, LH, bone-specific alkaline phosphatase (BAP), osteocalcin (OC), N-terminal telopeptides of type I collagen, C-terminal telopeptides of type I collagen, urinary NTX, urinary CTX, and urinary deoxypyridinoline (uDPD) were determined.

Results

All types of bone turnover indicator were significantly positively correlated with FSH (r = 0.164–0.626, all P = 0.000) and LH (r = 0.130–0.618, all P = 0.013–0.000). The correlation coefficient between serum FSH and BAP was the highest (r = 0.626), and that between serum FSH and uDPD was the lowest (r = 0.164). The serum gonadotropic hormone levels were higher; concentrations of bone turnover indicators were higher. The extent of the influence of FSH on various bone turnover indicators was approximately seven to 20 times greater than that of LH on these indicators. FSH could explain 43% and 22% of the changes in BAP and OC, respectively; whereas, LH could explain only 2.1% and 1.1%, respectively. FSH could explain approximately 1.9–11.8% of the changes in bone resorption indicators; however, LH had almost no effect on them.

Conclusions

Gonadotropic hormone levels are correlated with the rate of bone turnover in Chinese women: the higher the serum gonadotropic hormone levels in circulation, the higher the levels of bone turnover indicators. FSH has a greater influence on all types of bone turnover indicator than LH; moreover, it has a greater influence on bone formation indicators than on bone resorption indicators.

Keywords

Bone formative markers Bone resorptive markers Follicle-stimulating hormone Luteinizing hormone Osteoporosis 

Notes

Acknowledgments

This work was supported by the Ministry of Health of the People’s Republic of China (No. 2004–468–50). The authors thank Dr. Peng-Fei Shan, Ms. Yin-Zhen Pi, and Mr. Tuan-Yu Fang for their assistance.

Conflicts of interest

None.

References

  1. 1.
    National Osteoporosis Foundation (2006) Fast facts. http://www.nof.org/osteoporosis/diseasefacts.htm
  2. 2.
    Nagata-Kobayashi S, Shimbo T, Fukui T (2002) Cost-effectiveness analysis of screening for osteoporosis in postmenopausal Japanese women. J Bone Miner Metab 20:350–357CrossRefPubMedGoogle Scholar
  3. 3.
    Liu Z, Piao J, Pang L, Qing X, Nan S, Pan Z, Guo Y, Wang X, Li F, Lui J, Cheng X (2002) The diagnostic criteria for primary osteoporosis and the incidence of osteoporosis in China. J Bone Miner Metab 20:181–189CrossRefPubMedGoogle Scholar
  4. 4.
    Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279–302CrossRefPubMedGoogle Scholar
  5. 5.
    Prior JC (2006) FSH and bone—important physiology or not? Trends Mol Med 13:1–3CrossRefPubMedGoogle Scholar
  6. 6.
    Baron R (2006) FSH versus estrogen: who’s guilty of breaking bones? Cell Metab 3:302–305CrossRefPubMedGoogle Scholar
  7. 7.
    Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H, Zallone A, Sairam MR, Kumar TR, Bo W, Braun J, Cardoso-Landa L, Schaffler MB, Moonga BS, Blair HC, Zaidi M (2006) FSH directly regulates bone mass. Cell 125:247–260CrossRefPubMedGoogle Scholar
  8. 8.
    Devleta B, Adem B, Senada S (2004) Hypergonadotropic amenorrhea and bone density: new approach to and old problem. J Bone Miner Metab 22:360–364CrossRefPubMedGoogle Scholar
  9. 9.
    Yu Q, Lin S, He F, Li B, Lin Y, Zhang T, Zhang Y (2002) Clinical manifestations of low bone mass in amenorrhea patients with elevated follicular stimulating hormone. Chin Med J 115:1376–1379PubMedGoogle Scholar
  10. 10.
    Desai Meena P, Khatkhatay MI, Bhanu Prakash KV, Savardekar LS, Shah RS, Ansari Z (2007) Hormonal profiles and biochemical indices of bone turnover in Indian women. Osteoporos Int 18:923–929CrossRefPubMedGoogle Scholar
  11. 11.
    Xu ZR, Wang AH, Wu XP, Zhang H, Sheng ZF, Wu XY, Xie H, Luo XH, Liao EY (2009) Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women. Clin Chim Acta 400:8–13CrossRefPubMedGoogle Scholar
  12. 12.
    Zhao G, Wang L, Yan R, Dennerstein L (2000) Menopausal symptoms: experience of Chinese women. Climacteric 3:135–144CrossRefPubMedGoogle Scholar
  13. 13.
    Hui SL, Perkins AJ, Zhou L, Longcope C, Econs MJ, Peacock M, McClintock C, Johnston CC Jr (2002) Bone loss at the femoral neck in premenopausal white women: effects of weight change and sex-hormone levels. J Clin Endocrinol Metab 87:1539–1543CrossRefPubMedGoogle Scholar
  14. 14.
    Sowers MF, Jannausch M, McConnell D, Little R, Greendale GA, Finkelstein JS, Neer RM, Johnston J, Ettinger B (2006) Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 91:1261–1267CrossRefPubMedGoogle Scholar
  15. 15.
    Vural F, Vural B, Yucesoy I, Badur S (2005) Ovarian aging and bone metabolism in menstruating women aged 35–50 years. Maturitas 52:147–153CrossRefPubMedGoogle Scholar
  16. 16.
    Perrien DS, Achenbach SJ, Bledsoe SE, Walser B, Suva LJ, Khosla S, Gaddy D (2006) Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone. J Clin Endocrinol Metab 91:1848–1854CrossRefPubMedGoogle Scholar
  17. 17.
    Karim N, MacDonald D, Dolan AL, Fogelman I, Wierzbicki AS, Hampson G (2008) The relationship between gonadotrophins, gonadal hormones and bone mass in men. Clin Endocrinol (Oxf) 68:94–101CrossRefGoogle Scholar
  18. 18.
    Randolph JF Jr, Sowers M, Bondarenko IV, Harlow SD, Luborsky JL, Little RJ (2004) Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 89:1555–1561CrossRefPubMedGoogle Scholar
  19. 19.
    Randolph JF Jr, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N, McConnell DS, Finkelstein JS, Korenman SG, Matthews KA, Sternfeld B, Lasley BL (2003) Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 88:1516–1522CrossRefPubMedGoogle Scholar
  20. 20.
    Cohen FJ, Eckert S, Mitlak BH (1998) Geographic differences in bone turnover: data from a multinational study in healthy postmenopausal women. Calcif Tissue Int 63:277–282CrossRefPubMedGoogle Scholar
  21. 21.
    Chailurkit LO, Ongphiphadhanakul B, Piaseu N, Saetung S, Rajatanavin R (2001) Biochemical markers of bone turnover and response of bone mineral density to intervention in early postmenopausal women: an experience in a clinical laboratory. Clin Chem 47:1083–1088PubMedGoogle Scholar
  22. 22.
    Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15:1526–1536CrossRefPubMedGoogle Scholar
  23. 23.
    Garnero P, Ferreras M, Karsdal MA, Nicamhlaoibh R, Risteli J, Borel O, Qvist P, Delmas PD, Foged NT, Delaissé JM (2003) The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res 18:859–867CrossRefPubMedGoogle Scholar
  24. 24.
    Sendak RA, Sampath TK, McPherson JM (2007) Newly reported roles of thyroid-stimulating hormone and follicle-stimulating hormone in bone remodeling. Int Orthop 31:753–757CrossRefPubMedGoogle Scholar
  25. 25.
    Mansell JP, Bailey AJ, Yarram SJ (2007) Could bone tissue be a target for luteinizing hormone/chorionic gonadotropin? Mol Cell Endocrinol 169:99–106CrossRefGoogle Scholar
  26. 26.
    Ausmanas MK, Tan DA, Jaisamrarn U, Tian XW, Holinka CF (2007) Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia menopause (PAM) study. Climacteric 10:427–437CrossRefPubMedGoogle Scholar
  27. 27.
    Peichl P, Griesmacher A, Pointinger P, Marteau R, Hartl W, Gruber W, Bröll H (1998) Association between female sex hormones and biochemical markers of bone turnover in peri- and postmenopausal women. Calcif Tissue Int 62:388–394CrossRefPubMedGoogle Scholar
  28. 28.
    Sowers MR, Greendale GA, Bondarenko I, Finkelstein JS, Cauley JA, Neer RM, Ettinger B (2003) Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos Int 14:191–197CrossRefPubMedGoogle Scholar
  29. 29.
    Yasui T, Uemura H, Tomita J, Miyatani Y, Yamada M, Miura M, Irahara M (2006) Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women. J Endocrinol Invest 29:913–918PubMedGoogle Scholar
  30. 30.
    Iki M, Akiba T, Matsumoto T, Nishino H, Kagamimori S, Kagawa Y, Yoneshima H (2004) Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese population-based osteoporosis (JPOS) study. Osteoporos Int 15:981–991CrossRefPubMedGoogle Scholar
  31. 31.
    Liao EY, Wu XP, Deng XG, Huang G, Zhu XP, Long ZF, Wang WB, Tang WL, Zhang H (2000) Age-related bone mineral density, accumulated bone loss rate and prevalence of osteoporosis at multiple skeletal sites in chinese women. Osteoporos Int 13:669–676CrossRefGoogle Scholar
  32. 32.
    Wu XP, Liao EY, Zhang H, Shan PF, Cao XZ, Liu SP (2004) Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis. Osteoporos Int 15:71–79CrossRefPubMedGoogle Scholar
  33. 33.
    Zaidi M, Sun L, Kumar TR, Sairam MR, Blair H (2006) Both FSH and sex steroids influence bone mass. Cell 127:1080–1081CrossRefGoogle Scholar
  34. 34.
    Iqbal J, Sun L, Kumar TR, Blair HC, Zaidi M (2006) Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci USA 103:14925–14930CrossRefPubMedGoogle Scholar
  35. 35.
    Zaidi M, Blair HC, Iqbal J, Zhu LL, Kumar TR, Zallone A, Sun L (2007) Proresorptive actions of FSH and bone loss. Ann N Y Acad Sci 1116:376–382CrossRefPubMedGoogle Scholar
  36. 36.
    Seibel MJ, Dunstan CR, Zhou H, Allan CM, Handelsman DJ (2006) Sex steroids, not FSH, influence bone mass. Cell 127:1079CrossRefPubMedGoogle Scholar
  37. 37.
    Rajendren G, Zhou H, Moonga BS, Zaidi M, Sun L (2006) Restoration of bone mass in hpg mouse by preoptic area grafting. Ann N Y Acad Sci 1068:341–347CrossRefPubMedGoogle Scholar
  38. 38.
    Sims NA, Brennan K, Spaliviero J, Handelsman DJ, Seibel MJ (2006) Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling. Am J Physiol Endocrinol Metab 290:E456–E462CrossRefPubMedGoogle Scholar
  39. 39.
    Khosla S, Melton LJ 3rd, Atkinson EJ, O’Fallon WM, Klee GG, Riggs BL (1998) Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 83:2266–2274CrossRefPubMedGoogle Scholar
  40. 40.
    Desai MP, Bhanuprakash KV, Khatkhatay MI, Donde UM (2007) Age-related changes in bone turnover markers and ovarian hormones in premenopausal and postmenopausal Indian women. J Clin Lab Anal 21:55–60CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2009

Authors and Affiliations

  1. 1.Institute of Metabolism and Endocrinology, The Second Xiang-Ya HospitalCentral South UniversityChangshaPeople’s Republic of China

Personalised recommendations